Status: current, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3757029013 | Lorlatinib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3757030015 | Lorlatinib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lorlatinib | Is a | Lactam | true | Inferred relationship | Some | ||
| Lorlatinib | Has disposition | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Lorlatinib | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Lorlatinib | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Lorlatinib | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lorlatinib only product | Has active ingredient | True | Lorlatinib | Inferred relationship | Some | 1 |
| Lorlatinib-containing product in oral dose form | Has active ingredient | True | Lorlatinib | Inferred relationship | Some | 1 |
| Lorlatinib-containing product | Has active ingredient | True | Lorlatinib | Inferred relationship | Some | 1 |
| Lorlatinib only product in oral dose form | Has active ingredient | True | Lorlatinib | Inferred relationship | Some | 1 |
| Lorlatinib 100 mg oral tablet | Has precise active ingredient | True | Lorlatinib | Inferred relationship | Some | 1 |
| Lorlatinib 100 mg oral tablet | Has BoSS | True | Lorlatinib | Inferred relationship | Some | 1 |
| Lorlatinib 25 mg oral tablet | Has BoSS | True | Lorlatinib | Inferred relationship | Some | 1 |
| Lorlatinib 25 mg oral tablet | Has precise active ingredient | True | Lorlatinib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR